ResMed, Inc. Share Price
Stocks
RMD
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Cboe BZX
15:52:39 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 217.38 USD | -1.00% |
|
-4.97% | -9.91% |
| 09-10 | Resmed Insider Sold Shares Worth $1,110,191, According to a Recent SEC Filing | MT |
| 09-10 | Citigroup Adjusts Price Target on ResMed to $240 From $235, Keeps Neutral Rating | MT |
| Market Cap | 31.41B 27.02B 25.49B 23.22B 43.41B 3,003B 43.8B 304B 117B 1,523B 118B 115B 4,839B | P/E 2027 * |
18.8x | P/E 2028 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 30.46B 26.19B 24.72B 22.52B 42.09B 2,912B 42.47B 294B 113B 1,477B 114B 112B 4,692B | EV / Sales 2027 * |
5.24x | EV / Sales 2028 * | 4.8x |
| Free-Float |
75.13% | Yield 2027 * |
1.21% | Yield 2028 * | 1.33% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RMD | Delayed | |
CBOE
| RMD | Real-time | |
|
Mexican S.E.
| RMD * | End-of-day quote | |
|
Wiener Boerse
| RMD | End-of-day quote | |
|
Berne S.E.
| RME | End-of-day quote | |
|
Tradegate
| RME | Real-time | |
|
London S.E.
| 0KW4 | Delayed | |
|
Boerse Muenchen
| RME | Real-time | |
|
Deutsche Boerse AG
| RME | Delayed | |
|
Börse Stuttgart
| RME | Delayed | |
|
Borsa Italiana
| 1RMD | End-of-day quote |
Last Transcript : ResMed, Inc.
| 1 day | -0.96% | ||
| 1 week | -4.97% | ||
| Current month | -9.62% | ||
| 1 month | -3.49% | ||
| 3 months | +12.79% | ||
| 6 months | -9.64% | ||
| Current year | -9.91% |
| 1 week | 215.8 |  | 226.66 |
| 1 month | 215.8 | | 242.4 |
| Current year | 180.26 | | 277.67 |
| 1 year | 180.26 | | 284.87 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 297.62 |
| 10 years | 56.59 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 28/02/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 03/05/2026 |
| Chief Tech/Sci/R&D Officer | - | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 31/12/2004 |
Mick Farrell
CHM | Chairman | 53 | 24/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 31/05/1989 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/09/26 | Exercice | Chief Executive Officer | 14,973 | 0.0104% | ||
| 02/09/26 | Sell | Founder | -970 | 0.0007% | ||
| 07/08/26 | Exercice | Chief Executive Officer | 14,973 | 0.0103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.00% | -4.97% | -20.98% | +43.22% | 31.41B | |
| +0.92% | -0.97% | +23.68% | +18.03% | 223B | |
| +0.19% | -3.44% | +2.75% | -19.85% | 141B | |
| +2.45% | +0.84% | -18.88% | +22.30% | 127B | |
| +0.10% | -9.99% | -58.76% | -21.14% | 62.46B | |
| -0.25% | -1.79% | -20.21% | -15.38% | 49.73B | |
| -1.79% | -5.32% | +9.11% | +13.68% | 50.01B | |
| +1.79% | -3.82% | +14.50% | +28.29% | 40.35B | |
| +1.51% | -0.76% | +34.32% | +54.30% | 39.46B | |
| +2.78% | -6.80% | +104.80% | +31.43% | 30.39B | |
| Average | +0.68% | -3.72% | +7.03% | +15.49% | 79.52B | |
| Weighted average by Cap. | +0.79% | -3.36% | +4.41% | +10.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 5.81B 5B 4.72B 4.3B 8.03B 556B 8.1B 56.16B 21.61B 282B 21.82B 21.35B 895B | 6.19B 5.32B 5.02B 4.58B 8.55B 592B 8.63B 59.82B 23.02B 300B 23.25B 22.74B 953B |
| Net income | 1.64B 1.41B 1.33B 1.21B 2.27B 157B 2.29B 15.88B 6.11B 79.67B 6.17B 6.03B 253B | 1.78B 1.53B 1.45B 1.32B 2.46B 170B 2.48B 17.21B 6.62B 86.36B 6.69B 6.54B 274B |
| Net Debt | -955M -821M -775M -706M -1.32B -91.26B -1.33B -9.22B -3.55B -46.29B -3.58B -3.51B -147B | -1.69B -1.45B -1.37B -1.25B -2.34B -162B -2.36B -16.35B -6.29B -82.04B -6.35B -6.21B -261B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | US$217.12 | -1.12% | 122,077 |
| 10/09/26 | US$219.58 | -0.17% | 923,144 |
| 09/09/26 | US$219.95 | -0.50% | 1,200,149 |
| 08/09/26 | US$221.05 | -3.20% | 1,959,445 |
| 04/09/26 | US$228.35 | -0.37% | 843,837 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
